Specifically, overexpression of RBM3 reduces the expression of CD44v8-v10 and promotes the splicing of CD44s, which is known to have an inhibitory effect on metastasis, thus reducing the stemness properties of prostate cancer cells (PC3 cells). This evidence concerns the gene RBM3 and prostate carcinoma.